Mitral valve replacement with homograft and Maze III procedure
| Autor: | Donald B. Doty, Roger C. Millar, Karikehalli A Dilip |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine medicine.medical_specialty Heart disease medicine.medical_treatment Lesion Internal medicine Mitral valve Atrial Fibrillation medicine Humans Mitral Valve Stenosis cardiovascular diseases Heart valve Cardiac Surgical Procedures Aged business.industry Warfarin Mitral valve replacement Atrial fibrillation Middle Aged medicine.disease Surgery medicine.anatomical_structure cardiovascular system Cardiology Mitral Valve Female medicine.symptom Cardiology and Cardiovascular Medicine business Complication medicine.drug |
| Zdroj: | The Annals of Thoracic Surgery. 69:739-742 |
| ISSN: | 0003-4975 |
| DOI: | 10.1016/s0003-4975(99)01403-4 |
| Popis: | Background . Mitral valve disease is often accompanied by atrial fibrillation, which may compromise the patient even after the valvular lesion has been repaired. Methods . Three patients with rheumatic type mitral valve disease and chronic atrial fibrillation were treated by mitral valve replacement with cryopreserved mitral valve homograft and Maze III procedure, as a method to relieve both the valvular pathology and the rhythm disorder. The patients' clinical courses have been followed for up to 1 year after operation. Results . All patients survived operation, and all have normal sinus rhythm. None are taking cardiac medications. Conclusions . Long-term treatment with warfarin should not be required, and other cardiac medicines may be eliminated following mitral valve replacement with homograft combined with Maze III procedure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|